Simtra BioPharma Solutions, a contract development and manufacturing organisation (CDMO) focused on sterile injectables, has announced a five-year strategic partnership with the Life Science business of Merck KGaA, Darmstadt, Germany. Known as MilliporeSigma in the US and Canada, Merck’s Life
Unlocking Value Through Strategic Alignment and Flexibility Emerging biotech and pharmaceutical companies consistently face the intricate challenge of balancing time, cost, and risk. As these organisations strive to develop novel therapies and bring them to market, meticulous resource management is
“We invest to meet the needs of the customer. What’s driving these investments are really the customer partnerships that we’re building to make these happen,” explains Arul Ramadurai, Chief Commercial Officer at Axplora. Axplora, a global leader in API small
Cellex Cell Professionals, a European Contract Development and Manufacturing Organization (CDMO) focused on Cell & Gene Therapy (CGT), has announced the expansion of its GMP-certified manufacturing site. The facility now comprises more than 2,500 m², with 43% allocated to cleanroom
Ascend Advanced Therapies has received GMP certification for quality control (QC) testing at its site in Munich, Germany. The approval follows a joint inspection conducted by the government of Upper Bavaria and the Paul-Ehrlich-Institute in September 2024. The certification enables Ascend
Minerva Imaging, a science-focused Contract Research Organisation (CRO) and Contract Development and Manufacturing Organisation (CDMO), has entered a strategic partnership with Nordic Capital to scale its global radiopharmaceutical platform. The deal, which is subject to regulatory approvals, is expected to
Medicovestor, a biotechnology company based in New York, has entered into a strategic partnership with Sanyou Biopharmaceuticals, a Shanghai-based biologics specialist. The partnership, signed on 6 June, aims to jointly develop first-in-class chemoimmunotherapy antibody-drug conjugates (ADCs) targeting cancer and autoimmune diseases.
BioDuro, a global Contract Research, Development, and Manufacturing Organization (CRDMO), has entered into a partnership with Silicogenix (SGX) to enhance early-stage drug development. SGX is known for its proprietary small molecule design technology, which facilitates polypharmacology and non-traditional therapeutic approaches. The partnership
Phillips Medisize, a Molex company, has announced the launch of TheraVolt™, a new line of medical connectors engineered to support advanced device integration, performance, and reliability in electrophysiology (EP) applications. This is the first connector product line released under the
WuXi Biologics, a global Contract Research, Development and Manufacturing Organization (CRDMO), has announced the start of construction on its new microbial manufacturing facility in Chengdu’s Wenjiang district. The site, spanning 95,000 square metres, will serve as a commercial drug substance
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
